Potential Tumor-Selective Nitroimidazolylmethyluracil Prodrug Derivatives: Inhibitors of the Angiogenic Enzyme Thymidine Phosphorylase
- 12 December 2002
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (2) , 207-209
Abstract
Thymidine phosphorylase (TP) is an angiogenic growth factor and a target for anticancer drug design. Molecular modeling suggested that 2'-aminoimidazolylmethyluracils would be potent inhibitors of TP. The novel 5-halo-2-aminoimidazolylmethyluracils (4b/4c) were very potent inhibitors of E. coli TP (IC50 approximately 20 nM). Contrastingly, the corresponding 2'-nitroimidazolylmethyluracil (as bioreductively activated) prodrugs (3b/3c) were 1000-fold less active (IC50 22-24 microM). This approach may be used to selectively deliver TP inhibitors into hypoxic regions of solid tumors where TP is overexpressed.Keywords
This publication has 12 references indexed in Scilit:
- Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinomaCancer, 2002
- Synthesis and enzymatic evaluation of pyridinium-Substituted uracil derivatives as novel inhibitors of thymidine phosphorylaseBioorganic & Medicinal Chemistry, 2002
- Novel Nonsubstrate Inhibitors of Human Thymidine Phosphorylase, a Potential Target for Tumor-Dependent AngiogenesisJournal of Medicinal Chemistry, 2000
- Design, Synthesis, and Enzymatic Evaluation of Multisubstrate Analogue Inhibitors of Escherichia coli Thymidine PhosphorylaseJournal of Medicinal Chemistry, 2000
- The influence of elevated levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase on tumourigenicity, tumour growth, and oxygenationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Neurons of the peripheral nervous system express thymidine phosphorylaseNeuroscience Letters, 1995
- Thymidine phosphorylase is angiogenic and promotes tumor growth.Proceedings of the National Academy of Sciences, 1995
- Angiogenic factorNature, 1992
- Synthesis and evaluation of .alpha.-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of .alpha.-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxinsJournal of Medicinal Chemistry, 1990
- Inhibition of thymidine phosphorylase by 6-aminothymine and derivatives of 6-aminouracilBiochemical Pharmacology, 1967